SCHEMBL25663184

SCHEMBL25663184

c1ccc2nc(-c3ccc(N(c4ccc(-c5ccc6ccccc6n5)cc4)c4ccc(-c5ccc6c(n5)sc5ccccc56)cc4)cc3)ccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 14/20 0.44
▸ NPC1 O15118 13/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ AR P10275 2/20 0.44
▸ KDM4E B2RXH2 9/20 0.43
▸ SMN1; SMN2 Q16637 8/20 0.43
▸ ALDH1A1 P00352 7/20 0.43
▸ MAPT P10636 4/20 0.43
▸ CYP3A4 P08684 3/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ GMNN O75496 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ THPO P40225 1/20 0.43
▸ BLM P54132 1/20 0.43
▸ PMP22 Q01453 1/20 0.43
▸ CYP1A2 P05177 2/20 0.42
▸ CYP2D6 P10635 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25663221 0.91 RAB9A (0.39) RAB9ANPC1MEN1KMT2AKDM4E
SCHEMBL25663194 0.87 NPC1 (0.38) RAB9ANPC1MEN1KMT2AAR
SCHEMBL25663198 0.87 NPC1 (0.38) RAB9ANPC1MEN1KMT2AAR
SCHEMBL24055864 0.87 NPC1 (0.42) RAB9ANPC1MEN1KMT2AKDM4E
SCHEMBL25663197 0.87 APP (0.35) RAB9ANPC1MEN1KMT2AAR
SCHEMBL25663195 0.87 NPC1 (0.44) RAB9ANPC1MEN1KMT2AKDM4E
SCHEMBL25663216 0.86 APP (0.54) RAB9ANPC1MEN1KMT2AKDM4E
SCHEMBL25663228 0.86 ALDH1A1 (0.36) RAB9ANPC1MEN1KMT2AAR
SCHEMBL25663190 0.86 CYP1A2 (0.49) RAB9ANPC1MEN1KMT2AAR
SCHEMBL25663193 0.86 TGFBR1 (0.38) RAB9ANPC1KDM4ESMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE CHRM1, CHRM2, CHRM4 RAB9A 2198/4885NPC1 3859/4885MEN1 1967/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback